Core Viewpoint - The report indicates that 港通医疗 (Sichuan Porton Medical Equipment Group Co., Ltd.) is facing a projected loss for the year 2025, marking a significant shift from profit to loss, alongside delays in some fundraising projects due to external factors [1] Group 1: Stock Performance - As of February 3, 2026, 港通医疗's stock closed at 25.21 yuan, reflecting a 4.0% increase from the previous trading day [1] - The stock opened at 24.76 yuan, reached a high of 25.47 yuan, and a low of 24.22 yuan, with a trading volume of 73.46 million yuan and a turnover rate of 4.51% [1] Group 2: Regulatory Compliance - The report from 中信建投证券 (CITIC Securities) regarding the 2025 annual continuous supervision inspection indicates that the company is generally compliant in areas such as corporate governance, internal control, information disclosure, and use of raised funds [1] - However, the company is expected to incur a loss between 2 million to 4 million yuan for the year 2025, which is a reversal from previous profits [1] - Some fundraising projects are experiencing slower construction progress than anticipated, leading to the execution of delay procedures and subsequent announcements [1]
港通医疗（301515）披露2025年度持续督导定期现场检查报告，2月3日股价上涨4.0%